Skip to main content

Table 4 Sensitivity analyses

From: Cost-effectiveness of polymyxin B hemoperfusion for septic shock: an observational study using a Japanese nationwide administrative database

 

Reduction rate for LYG estimation

Utility weight for QALY estimation

Difference in cost (Euro)

Difference in life expectancy (yrs)

Difference in LYG (years)

Difference in QALY (years)

ICER (Euro/year)

Case 1 (base case)

0.51

0.69

6935

1.70

0.87

0.60

11,592

Case 2

0.3

0.6

6935

1.70

0.51

0.31

22,663

Case 3

0.7

0.8

6935

1.70

1.19

0.95

7285

  1. LYG Life year gained, QALY Quality-adjusted life-year, ICER Incremental cost-effectiveness ratio